Roboearth – Lifestyle
Author:
Capwell Communications
JASMINE Trial Demonstrates Prolacta’s Human Milk-Based Fortifiers Deliver Superior Growth in Premature Infants While Maintaining Japan’s Renowned Low NEC Rate
April 30, 2026